Abstract
The introduction of oxygen atoms into different positions of the vitamin D side chain is described. By combining the arising 23-oxa and 25-oxa elements with other structural modifications (19-nor, iso-19-nor, 20-methyl, 20-ene, 20,21-cyclo) calcitriol analogs with remarkable levels of dissociation between beneficial acitivities on cell growth regulation and undesired hypercalcemia were identified. Structure-activity relations are elaborated in a very systematic outline of the Schering drug finding program in this particular class of vitamin D compounds.
Keywords: Antiproliferative Activities, 23 Oxa Calcitriols, 19 Nor 23 oxa Calcitriols, Iso 19 nor 23 oxa Calcitriols, 20 Methyl 23 oxa calcitriols, 20 Ene 23 oxa Calcitriol, 20 Ene 19 nor 23 oxa Calcitriols, 20 21 Cyclo 23 oxa calcitriols, 25 oxa Calcitriols, Relative binding affinity, Vitamin D receptor, 1 4 Diazabicyclo 2 2 2 octane, Diisobutylaluminum hydride, Vitamin D binding prtien, Human leukemia cell line, Lithium diisopropylamide
Current Pharmaceutical Design
Title: New Synthetic Vitamin D Analogs with Antiproliferative Activities
Volume: 6 Issue: 7
Author(s): Andreas Steinmeyer, Gerald Kirsch, Gunter Neef and Katica Schwarz
Affiliation:
Keywords: Antiproliferative Activities, 23 Oxa Calcitriols, 19 Nor 23 oxa Calcitriols, Iso 19 nor 23 oxa Calcitriols, 20 Methyl 23 oxa calcitriols, 20 Ene 23 oxa Calcitriol, 20 Ene 19 nor 23 oxa Calcitriols, 20 21 Cyclo 23 oxa calcitriols, 25 oxa Calcitriols, Relative binding affinity, Vitamin D receptor, 1 4 Diazabicyclo 2 2 2 octane, Diisobutylaluminum hydride, Vitamin D binding prtien, Human leukemia cell line, Lithium diisopropylamide
Abstract: The introduction of oxygen atoms into different positions of the vitamin D side chain is described. By combining the arising 23-oxa and 25-oxa elements with other structural modifications (19-nor, iso-19-nor, 20-methyl, 20-ene, 20,21-cyclo) calcitriol analogs with remarkable levels of dissociation between beneficial acitivities on cell growth regulation and undesired hypercalcemia were identified. Structure-activity relations are elaborated in a very systematic outline of the Schering drug finding program in this particular class of vitamin D compounds.
Export Options
About this article
Cite this article as:
Steinmeyer Andreas, Kirsch Gerald, Neef Gunter and Schwarz Katica, New Synthetic Vitamin D Analogs with Antiproliferative Activities, Current Pharmaceutical Design 2000; 6 (7) . https://dx.doi.org/10.2174/1381612003400470
DOI https://dx.doi.org/10.2174/1381612003400470 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nuclear Receptors CAR and PXR in Metabolism and Elimination of Drugs
Current Pharmacogenomics Critical Role of the Endocannabinoid System in the Regulation of Food Intake and Energy Metabolism, with Phylogenetic, Developmental, and Pathophysiological Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets FXR, A Therapeutic Target for Bile Acid and Lipid Disorders
Mini-Reviews in Medicinal Chemistry Segmentation and Classification of Lung Cancer: A Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) D-amino Acids as Novel Blood-based Biomarkers
Current Medicinal Chemistry subject Index To Volume 2
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Valproic Acid Metabolism and its Consequences on Sexual Functions
Current Drug Metabolism From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
Current Pharmaceutical Design Nuclear Imaging and Early Breast Cancer Detection
Current Radiopharmaceuticals Comparative Approach of the de novo Fatty Acid Synthesis (Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From Biochemical Level to the Main Regulatory Lipogenic Genes
Current Genomics Functional Signaling Biases in G Protein-Coupled Receptors: Game Theory and Receptor Dynamics
Mini-Reviews in Medicinal Chemistry Recent Advances in Gene Therapy of Endometriosis
Recent Patents on DNA & Gene Sequences Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
Current Pharmaceutical Design Sulfotransferase Inhibition: Potential Impact of Diet and Environmental Chemicals on Steroid Metabolism and Drug Detoxification
Current Drug Metabolism The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
Current Pharmaceutical Biotechnology Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?
Current Pharmaceutical Design Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
Current Pharmaceutical Design Breast Cancer and Anesthesia
Current Pharmaceutical Design Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration
CNS & Neurological Disorders - Drug Targets Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices
Current Pharmaceutical Design